JRCT ID: jRCT1080223836
Registered date:07/03/2018
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 02/10/2017 |
Target sample size | 65 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Tenofovir Disoproxil Fumarate Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : - |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | safety efficacy exploratory |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 69age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | GlaxoSmithKline K.K. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03258710,JapicCTI-183892 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
https://glaxosmithkline.co.jp/legal/inquire3_1.html | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
https://glaxosmithkline.co.jp/legal/inquire3_1.html | |
Affiliation |